Richard O'Brien

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Systemic Lupus Erythematosus

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Roy Rasalam, Sarah Abdo, Gary Deed, Richard O'Brien, Jane Overland
Early type 2 diabetes treatment intensification with glucagon-like peptide-1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence. Diabetes, obesity & metabolism 25 (4) (2023)
Roy Rasalam, Sarah Abdo, Gary Deed, Richard O'Brien, Jane Overland
Early type 2 diabetes treatment intensification with glucagon-like peptide-1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence. Diabetes, obesity & metabolism 25 (4) (2023)
Roy Rasalam, Sarah Abdo, Gary Deed, Richard O'Brien, Jane Overland
Early type 2 diabetes treatment intensification with glucagon-like peptide-1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence. Diabetes, obesity & metabolism 25 (4) (2023)
Roy Rasalam, Sarah Abdo, Gary Deed, Richard O'Brien, Jane Overland
Early type 2 diabetes treatment intensification with glucagon-like peptide-1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence. Diabetes, obesity & metabolism (2022)